Caption Management, LLC Adverum Biotechnologies, Inc. Call Options Transaction History

Caption Management, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2020 Aug 14, 2020	SELL	$8.53 - $25.64 $213,249 - $641,000	-25,000 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$5.12 - $12.22 $166,400 - $397,150	-32,500 Reduced 56.52%	25,000 $288,000
Q3 2019 Nov 14, 2019	BUY	$5.24 - $15.89 $301,300 - $913,675	57,500 New	57,500 $314,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.